Literature DB >> 16966556

Subcortical white matter abnormalities related to drug resistance in Wilson disease.

D Aikath1, A Gupta, I Chattopadhyay, M A Hashmi, P K Gangopadhyay, S K Das, K Ray.   

Abstract

Wilson disease (WD) produces typical lesions in the brain, which can aid in diagnosis and therapy. The authors present a drug-resistant WD case with atypical cerebral lesions with marked involvement of white matter as visualized on MRI scans. The diagnosis was confirmed by identification of mutations in the ATP7B gene. The case demonstrates an uncommon pathology-related cerebral copper accumulation and emphasizes the importance of genetic screening in the diagnosis of WD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966556     DOI: 10.1212/01.wnl.0000234130.27871.03

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

2.  Altered large-scale functional brain networks in neurological Wilson's disease.

Authors:  Rixing Jing; Yongsheng Han; Hewei Cheng; Yongzhu Han; Kai Wang; Daniel Weintraub; Yong Fan
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

3.  A novel COMMD1 mutation Thr174Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson Disease patient.

Authors:  Arnab Gupta; Ishita Chattopadhyay; Shashwata Mukherjee; Mainak Sengupta; Shyamal K Das; Kunal Ray
Journal:  Behav Brain Funct       Date:  2010-06-15       Impact factor: 3.759

4.  Neuroacanthocytosis: A rare movement disorder with magnetic resonance imaging.

Authors:  G Gautam; Ma Hashmi; Arindam Pandey
Journal:  J Neurosci Rural Pract       Date:  2011-01

5.  Unusual epileptic deterioration and extensive white matter lesion during treatment in Wilson's disease.

Authors:  Young Eun Kim; Ji Young Yun; Hui-Jun Yang; Han-Joon Kim; Beom S Jeon
Journal:  BMC Neurol       Date:  2013-09-25       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.